pentoxifylline has been researched along with Diabetic Neuropathies in 18 studies
Diabetic Neuropathies: Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To test the effectiveness of pentoxifylline as a therapy for diabetic impotence." | 9.08 | Trial of pentoxifylline for diabetic impotence. ( Georgitis, WJ; Merenich, JA, 1995) |
| "To test the effectiveness of pentoxifylline as a therapy for diabetic impotence." | 5.08 | Trial of pentoxifylline for diabetic impotence. ( Georgitis, WJ; Merenich, JA, 1995) |
| "Pentoxifylline has been shown to improve circulation through partially occluded peripheral vessels and has been postulated to be of potential benefit." | 2.67 | Pentoxifylline in the treatment of distal diabetic neuropathy. ( Cohen, SM; Mathews, T, 1991) |
| "Clonidine was administered to 16 subjects at two dosage levels (0." | 2.67 | Lack of effect of clonidine and pentoxifylline in short-term therapy of diabetic peripheral neuropathy. ( Chomiak, M; Cohen, KL; Lucibello, FE, 1990) |
| "Peripheral neuropathy, infection, and peripheral vascular disease can produce serious problems in diabetic patients, particularly in the lower limbs." | 1.28 | Lower limb problems in diabetic patients. What are the causes? What are the remedies? ( Bell, DS, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (16.67) | 18.7374 |
| 1990's | 10 (55.56) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Dastgheib, M | 2 |
| Shetab-Boushehri, SV | 1 |
| Baeeri, M | 1 |
| Gholami, M | 1 |
| Karimi, MY | 1 |
| Hosseini, A | 2 |
| Falak, R | 1 |
| Moghaddam, MV | 1 |
| Hassanzadeh, G | 1 |
| Safa, M | 1 |
| Laczy, B | 1 |
| Cseh, J | 1 |
| Mohás, M | 1 |
| Markó, L | 1 |
| Tamaskó, M | 1 |
| Koszegi, T | 1 |
| Molnár, GA | 1 |
| Wagner, Z | 1 |
| Wagner, L | 1 |
| Wittmann, I | 1 |
| Medvedeva, LA | 1 |
| Gnezdilov, AV | 1 |
| Zagorul'ko, OI | 1 |
| Syrovegin, AV | 1 |
| Samoĭlova, NV | 1 |
| Slashchuk, IuI | 1 |
| Wernicke, JF | 1 |
| Wang, F | 1 |
| Pritchett, YL | 1 |
| Smith, TR | 1 |
| Raskin, J | 1 |
| D'Souza, DN | 1 |
| Iyengar, S | 1 |
| Chappell, AS | 1 |
| Georgitis, WJ | 1 |
| Merenich, JA | 1 |
| Ely, H | 1 |
| McDaniel, MD | 1 |
| McCarty, MF | 1 |
| Kayal, A | 1 |
| Rendell, M | 1 |
| Bamisedun, O | 1 |
| Sainati, SM | 1 |
| Cohen, SM | 1 |
| Mathews, T | 1 |
| Bell, DS | 1 |
| Cohen, KL | 2 |
| Lucibello, FE | 1 |
| Chomiak, M | 1 |
| Kalmansohn, RB | 1 |
| Kalmansohn, RW | 1 |
| Markham, CH | 1 |
| Schiff, DL | 1 |
| Harris, S | 1 |
| Pierce, WL | 1 |
| Crowhurst, JA | 1 |
| Caneva, RG | 1 |
7 trials available for pentoxifylline and Diabetic Neuropathies
| Article | Year |
|---|---|
Effects of pentoxifylline and pentosan polysulphate combination therapy on diabetic neuropathy in type 2 diabetes mellitus.
Topics: Albuminuria; Anticoagulants; Autonomic Nervous System; Blood Pressure; Body Mass Index; Creatinine; | 2009 |
[Neurometabolic therapy of diabetic neuropathy].
Topics: Adjuvants, Immunologic; Analgesics, Non-Narcotic; Antioxidants; Blood Glucose; Carbamazepine; Diabet | 2006 |
An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic pain.
Topics: Acetaminophen; Amitriptyline; Analgesics; Carbamazepine; Diabetes Complications; Diabetic Neuropathi | 2007 |
Trial of pentoxifylline for diabetic impotence.
Topics: Aged; Analysis of Variance; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Double-Blind Method; E | 1995 |
Pentoxifylline and diabetic neuropathy.
Topics: Diabetic Neuropathies; Humans; Pentoxifylline | 1991 |
Pentoxifylline in the treatment of distal diabetic neuropathy.
Topics: Diabetes Mellitus, Type 2; Diabetic Neuropathies; Double-Blind Method; Electromyography; Humans; Mid | 1991 |
Lack of effect of clonidine and pentoxifylline in short-term therapy of diabetic peripheral neuropathy.
Topics: Clonidine; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Double-Blind Method; Drug Evaluation; H | 1990 |
11 other studies available for pentoxifylline and Diabetic Neuropathies
| Article | Year |
|---|---|
Rolipram and pentoxifylline combination ameliorates experimental diabetic neuropathy through inhibition of oxidative stress and inflammatory pathways in the dorsal root ganglion neurons.
Topics: Adenosine Monophosphate; Animals; Biomarkers; Cyclooxygenase 2; Diabetic Neuropathies; Ganglia, Spin | 2022 |
Rolipram and pentoxifylline combination ameliorates the morphological abnormalities of dorsal root ganglion neurons in experimental diabetic neuropathy by reducing mitochondrial dysfunction and apoptosis.
Topics: Adenosine Triphosphate; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cytochromes c; Di | 2023 |
Is pentoxifylline the drug of the decade?
Topics: Clinical Trials as Topic; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Human | 1994 |
A 52-year-old woman with diabetes and claudication.
Topics: Coronary Disease; Decision Making; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephro | 1998 |
Nitric oxide deficiency, leukocyte activation, and resultant ischemia are crucial to the pathogenesis of diabetic retinopathy/neuropathy--preventive potential of antioxidants, essential fatty acids, chromium, ginkgolides, and pentoxifylline.
Topics: Animals; Antioxidants; Chromium; Diabetic Angiopathies; Diabetic Neuropathies; Diabetic Retinopathy; | 1998 |
Diabetic peripheral neuropathy.
Topics: Diabetic Neuropathies; Humans; Infusions, Intravenous; Pentoxifylline | 1992 |
Skin blood flow and current perception in pentoxifylline-treated diabetic neuropathy.
Topics: Adolescent; Adult; Aged; Diabetic Neuropathies; Drug Evaluation; Electric Stimulation; Humans; Laser | 1992 |
Lower limb problems in diabetic patients. What are the causes? What are the remedies?
Topics: Amputation, Surgical; Anti-Bacterial Agents; Clinical Protocols; Debridement; Diabetes Complications | 1991 |
Treatment of diabetic neuropathy with pentoxifylline: case report.
Topics: Aged; Aged, 80 and over; Diabetic Neuropathies; Humans; Male; Pain, Intractable; Pentoxifylline; The | 1988 |
Pentoxifylline and diabetic neuropathy.
Topics: Diabetic Neuropathies; Humans; Pentoxifylline; Theobromine | 1987 |
Pentoxifylline. A new drug review and case report.
Topics: Aged; Diabetic Neuropathies; Humans; Intermittent Claudication; Male; Pentoxifylline; Theobromine | 1986 |